Avidity Biosciences, Up 441%, Nears Another Record High As Dystrophy Space Heats Up

Avidity Biosciences, Up 441%, Nears Another Record High As Dystrophy Space Heats Up · Investor's Business Daily
ALLISON GATLIN
6 min read

In This Article:

The three-horse race to treat a devastating form of muscular dystrophy is now down to two. And Avidity Biosciences is feeling bullish.

Recommended Stories